期刊文献+

铁负荷过载研究进展及治疗 被引量:10

Iron overload:advances in research and treatment
原文传递
导出
摘要 铁是人体必需营养元素,广泛参与机体生理功能和生化反应。当体内铁过多时则称为铁负荷过载。随着医疗条件改善、生活水平提高,源于生理性因素、病理性因素和外源性铁剂应用(治疗性应用、预防性应用),铁负荷过载相关疾病日益增多。铁过载可对内分泌代谢、心血管、神经系统、肝脏等系统器官产生损害,导致多种疾病或使疾病加重。本文就铁负荷过载的病因、发病机制、组织损伤及治疗研究进展做一综述。 Iron is an essential nutrition element of human body and participates in a wide range of physiological functions and biochemical procedures.Along with the improving medical services and better living standard,excessive supply of iron in the body that arise from psychological or pathological factors or use of iron supplements(for therapeutic or preventive purposes),known as iron overload,has been increasingly linked to a variety of diseases.Iron overload can be harmful to endocrinal metabolism,cardiovascular system,nervous system,liver and other organs in the body,and may induce or deteriorate a number of diseases.Updates in etiology,pathogenesis,tissue injury and treatment of iron overload were reviewed in this paper.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2010年第12期1141-1142,共2页 Chinese Journal of Practical Internal Medicine
基金 国家自然科学基金(30971285) 国家"十一五"科技支撑项目(2008BAI61B02)
关键词 铁过载 相关疾病 去铁治疗 iron overload related diseases iron removal treatment
  • 相关文献

参考文献7

  • 1Valenti L, Pulixi EA, Arosio P, et al. Relative contribution of iron genes, dysmetabolism and hepatitis C virus(HCV) in the pathogen- esis of altered iron regulation in HCV chronic hepatitis [ J ]. Haematologica ,2007,92 : 1037 - 1042.
  • 2Nordestgaard BG, Adourian AS, Freiberg JJ, et al. Risk factors for near-term myocardial infarction in apparently healthy men and women [ J ]. Clin Chem,2010 ,56 :559 - 567.
  • 3McClain DA, Abraham D, Rogers J, et al. High prevalence of ab- normal glucose homeostasis secondary to decreased insulin secre- tion in individuals with hereditary haemochromatosis[ J]. Diabeto- logia,2006,49 : 1661 - 1669.
  • 4Au WY,Lam WW,Chu W,et al. A T2 magnetic resonance imaging study of pancreatic iron overload in thalassemia major[ J]. Haema- tologica,2008,93 : 116 - 119.
  • 5Malcovati L, Della Porta MG, Cazzola M. Predicting survival and leukemic evolution in patients with myelodysplastic syndrome[ J]. Haematalogica,2006,91 : 1588 - 1590.
  • 6Kattamis A, Dinopoulos A, Ladis V, et al. Variations of ferritin lev- els over a period of 15 years as a compliance chelation index in thalassemic patients [ J ]. Am J Hematol,2001,68 :221 - 224.
  • 7Cappellini MD, Taher A. Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload [ J ]. Expert Opin Pharmacother, 2008, 9:2391 - 2402.

同被引文献54

引证文献10

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部